"10.1371_journal.pone.0095524","plos one","2014-05-06T00:00:00Z","John E McKinnon; Robbie B Mailliard; Susan Swindells; Timothy J Wilkin; LuAnn Borowski; Jillian M Roper; Barbara Bastow; Mary Kearney; Ann Wiegand; John W Mellors; Charles R Rinaldo; for the A5201 study team","Henry Ford Hospital System, Detroit, Michigan, United States of America; University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; University of Nebraska Medical Center, Omaha, Nebraska, United States of America; Weill-Cornell Medical College, New York, New York, United States of America; George Washington University, Washington, DC, United States of America; Social & Scientific Systems, Inc., Silver Spring, Maryland, United States of America; HIV Drug Resistance Program, NCI, Frederick, Maryland, United States of America","Conceived and designed the experiments: JEM RBM SS TJW JWM CRR. Performed the experiments: JEM RBM LB JMR MK AW. Analyzed the data: JEM RBM LB JMR MK AW JWM CRR. Contributed reagents/materials/analysis tools: JEM RBM LB JMR MK AW BB JWM CRR. Wrote the paper: JEM RBM SS TJW LB JMR BB MK AW JWM CRR. Regulatory and study development: BB.","JEM received grant support (paid to the University of Pittsburgh and Henry Ford Hospital) from Abbott Molecular. SS receives grant support (paid to the University of Nebraska Medical Center) from Pfizer and Glaxo-Smith Kline. TW receives grant support (paid to Weill-Cornell) from Tibotec and Glaxo-Smith Kline. JWM is a consultant for Gilead Sciences and owns share options in RFS Pharma. BB is an employee of Social & Scientific Systems, Inc. There are no patents, products in development or marketed products to declare. This does not alter adherence to all the PLOS ONE policies on sharing data and materials.","2014","05","John E McKinnon","JEMK",12,TRUE,6,6,8,11,TRUE,TRUE,TRUE,1,"12",TRUE
